BerGenBio
Clinical-stage biopharma that developed selective AXL kinase inhibitors for cancer.
BGBIO | OL
Overview
Corporate Details
- ISIN(s):
- NO0012921180 (+2 more)
- LEI:
- 213800TYYFXKYF3V2A23
- Country:
- Norway
- Address:
- MØLLENDALSBAKKEN 9, 5009 BERGEN
- Website:
- https://www.bergenbio.com/
- Sector:
- Manufacturing
Description
BerGenBio was a clinical-stage biopharmaceutical company focused on developing first-in-class selective AXL kinase inhibitors. The company's therapeutic candidates targeted AXL as a potential cornerstone of therapy for aggressive, advanced, and treatment-resistant cancers. In October 2025, BerGenBio completed a merger with Oncoinvent ASA, and the combined entity was renamed Oncoinvent.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-06-03 14:45 |
BerGenBio provides interim update on Phase II clinical programme with selective…
|
English | 10.6 KB | ||
| 2018-06-02 12:55 |
BerGenBio ASA US CLINICAL TRIAL UPDATE
|
English | 3.8 KB | ||
| 2018-05-29 06:00 |
BerGenBio - Invitation to conference call: interim update on Ph II clinical pro…
|
English | 6.5 KB | ||
| 2018-05-23 15:03 |
BerGenBio ASA: Share options to primary insiders
|
English | 2.3 KB | ||
| 2018-05-18 08:00 |
BerGenBio to present interim clinical and biomarker data with selective AXL inh…
|
English | 4.9 KB | ||
| 2018-05-16 21:00 |
BerGenBio to present interim clinical and biomarker data from Phase II developm…
|
English | 7.5 KB | ||
| 2018-05-15 05:00 |
BerGenBio ASA: Results for the First Quarter 2018
|
English | 40.6 KB | ||
| 2018-05-15 05:00 |
BerGenBio ASA: Results for the First Quarter 2018
|
English | 3.8 MB | ||
| 2018-05-15 05:00 |
BerGenBio ASA: Results for the First Quarter 2018
|
English | 11.1 MB | ||
| 2018-05-15 05:00 |
BerGenBio ASA: Results for the First Quarter 2018
|
English | 8.8 KB | ||
| 2018-05-14 10:30 |
BerGenBio participation at upcoming healthcare investor and life sciences indus…
|
English | 5.5 KB | ||
| 2018-05-14 10:25 |
BerGenBio ASA: Annual General Meeting
|
Norwegian | 390.3 KB | ||
| 2018-05-14 10:25 |
BerGenBio ASA: Annual General Meeting
|
English | 1.5 KB | ||
| 2018-05-08 14:01 |
BerGenBio ASA: Invitation to First Quarter 2018 Results Presentation and Webcast
|
English | 2.3 KB | ||
| 2018-04-23 13:44 |
BerGenBio ASA (BGBIO): Notice of annual general meeting
|
English | 184.6 KB |
Automate Your Workflow. Get a real-time feed of all BerGenBio filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BerGenBio
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BerGenBio via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
